MedPath

HO-1 and Muscle Mitochondrial Dysfunction in Sepsis

Conditions
Sepsis
Atrophy
Registration Number
NCT02359240
Lead Sponsor
Changhai Hospital
Brief Summary

The current project was designed to examine dynamic changes in muscle wasting during sepsis. Researchers will focus the mitochondrial dysfunction of muscle cells and investigate the role of HO-1 in it. Researchers interested in identifying factors involved in the pathology of muscle wasting during sepsis.

Detailed Description

Rapid muscle atrophy or muscle wasting occured to septic patients.Sepsis induced muscle wasting has become a severe, frequent, and persistent complication among critically ill patients. Multiple factors including ubiquitin-proteasome system, proinflammatory cytokines and oxidative stress contribute muscle proteolysis.

It is known that heme oxygenase-1 (HO-1) possesses a variety of functions like anti-inflammatory, antioxidative and anti-apoptosis effects. In order to investigate the mechanisms under the condition, researchers are going to examine the role of HO-1 in muscle atrophy during sepsis.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
50
Inclusion Criteria
  • sepsis, severe sepsis, septic shock
  • clinical reason for fixation surgery of femoral fractures
Exclusion Criteria
  • no informed consent
  • medical history of myopathy
  • unintended weight loss before surgery or ICU admission
  • chronic use of corticosteroids

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
HO-1 mRNA and protein expression, mitochondria function of musculus vastus lateralis3 days after diagnosis
Secondary Outcome Measures
NameTimeMethod
length of ICU stay60 days
muscle myosin content3 days after diagnosis
length of mechanical ventilation60 days

Trial Locations

Locations (1)

Anesthesiology and Intensive Care, Changhai Hospital

🇨🇳

Shanghai, Shanghai, China

Anesthesiology and Intensive Care, Changhai Hospital
🇨🇳Shanghai, Shanghai, China

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.